PHARMASUM THERAPEUTICS AS
Operating
Pharmasum Therapeutics - Home
Utvikling, markedsføring, fremstilling/salg av farmasøytiske og
bioteknologiske produkter og andre produkter som naturlig faller
sammen med dette, herunder å delta i andre selskaper med lignende
virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg
interessert i andre foretagender.
Forskning og utviklingsarbeid innen bioteknologi og farmasi.
Links
Organization
- CEO
- AK
- Chairman of the board
- AK
- Years since formation
- 12 years
- since Jun 17, 2014
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 3,166,419
- 1 share class
- Total number of shareholders
- 682
- 194 companies, 488 persons
Financials
- Total operating income 2024
- 989,892
- NOK
- Annual total result 2024
- -2,810,897
- NOK
- Total equity 2024
- -25,575
- NOK
Last update: Dec 12, 2025
Locations
- Company addressShareLab Forskningsparken i Oslo Gaustadalléen 21 0349 OSLO, Norge
Copied! - Postal addressc/o Anders Fugelli General Fleischers vei 12B 1359 EIKSMARKA, Norge
Copied!
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AK | Managing Director/CEO | 10.95 % directly 3.04 % indirectly 7.9 % |
Board
| Name | Role | Shares |
|---|---|---|
AK | Chairman | 10.95 % directly 3.04 % indirectly 7.9 % |
ØS 1969 | Board Member | - |
| Board Member | 4.34 % directly 0.26 % indirectly 4.08 % | |
RJ | Board Member | - |
TB 1961 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
R REVICOM AS | Auditor | - |
T TANDEM AS | Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
AK | Managing Director/CEO, Chairman | 10.95 % directly 3.04 % indirectly 7.9 % |
| Board Member | 4.34 % directly 0.26 % indirectly 4.08 % | |
TH 1990 | - | 4.08 % indirectly |
SH 1980 | - | 4.08 % indirectly |
ØH | - | 4.08 % indirectly |
RH 1978 | - | 4.08 % indirectly |
HH 1995 | - | 4.08 % indirectly |
HR 1988 | - | 4.08 % indirectly |
| - | 4.08 % indirectly | |
JH 1951 | - | 4.02 % indirectly |
Last update: Jan 15, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
J JAHATT AS Closed | Ordinary shares | 485,085 | 15.32 % |
J JAKOB HATTELAND HOLDING AS | Ordinary shares | 414,954 | 13.1 % |
P PHARMAPATENT AS | Ordinary shares | 258,340 | 8.16 % |
F FUGELLI INVEST AS | Ordinary shares | 250,250 | 7.9 % |
I INVEN2 AS | Ordinary shares | 103,448 | 3.27 % |
AK | Ordinary shares | 96,307 | 3.04 % |
N NORTH MURRAY AS | Ordinary shares | 76,930 | 2.43 % |
P PHARMA HOLDINGS AS | Ordinary shares | 68,142 | 2.15 % |
H HEYERN AS | Ordinary shares | 67,560 | 2.13 % |
B BENT ERIKSEN AS | Ordinary shares | 63,800 | 2.01 % |
BK | Ordinary shares | 58,333 | 1.84 % |
| Ordinary shares | 41,941 | 1.32 % | |
MS | Ordinary shares | 41,666 | 1.32 % |
T TAJ HOLDING AS | Ordinary shares | 37,616 | 1.19 % |
P PICASSO AS | Ordinary shares | 37,099 | 1.17 % |
C CARE HOLDING AS | Ordinary shares | 36,044 | 1.14 % |
D DREXCIYA AS | Ordinary shares | 34,483 | 1.09 % |
EO 1953 | Ordinary shares | 33,333 | 1.05 % |
BR | Ordinary shares | 32,000 | 1.01 % |
L LUKAS I AS | Ordinary shares | 30,000 | 0.95 % |
RV 1935 | Ordinary shares | 25,000 | 0.79 % |
N NORINNOVA INVEST AS | Ordinary shares | 23,362 | 0.74 % |
S SYNOVIA AS | Ordinary shares | 21,800 | 0.69 % |
SG 1944 | Ordinary shares | 21,666 | 0.68 % |
AA 1940 | Ordinary shares | 20,833 | 0.66 % |
PG | Ordinary shares | 20,833 | 0.66 % |
JE | Ordinary shares | 20,833 | 0.66 % |
SI | Ordinary shares | 20,833 | 0.66 % |
PJ 1943 | Ordinary shares | 20,833 | 0.66 % |
KR | Ordinary shares | 20,833 | 0.66 % |
C CHIVIRICO AS | Ordinary shares | 20,833 | 0.66 % |
L LYSNES INVEST AS | Ordinary shares | 20,719 | 0.65 % |
GE | Ordinary shares | 20,000 | 0.63 % |
KA | Ordinary shares | 20,000 | 0.63 % |
A ARVO INVEST AS | Ordinary shares | 17,250 | 0.54 % |
KF 1962 | Ordinary shares | 15,892 | 0.5 % |
A ABAKUS INVEST AS | Ordinary shares | 15,071 | 0.48 % |
KM | Ordinary shares | 15,000 | 0.47 % |
JP | Ordinary shares | 14,594 | 0.46 % |
H HOPEN INVEST AS | Ordinary shares | 14,126 | 0.45 % |
3 3T PRODUKTER HOLDING AS | Ordinary shares | 12,328 | 0.39 % |
K KLØKTIG INVEST AS | Ordinary shares | 12,000 | 0.38 % |
| Ordinary shares | 11,701 | 0.37 % | |
TH | Ordinary shares | 10,061 | 0.32 % |
JP | Ordinary shares | 10,000 | 0.32 % |
P PER STRAND EIENDOM AS | Ordinary shares | 9,402 | 0.3 % |
4 4 LB INVEST AS | Ordinary shares | 8,533 | 0.27 % |
| Ordinary shares | 8,340 | 0.26 % | |
TF 1953 | Ordinary shares | 8,340 | 0.26 % |
AO | Ordinary shares | 8,333 | 0.26 % |
N NORINNOVA AS | Ordinary shares | 8,307 | 0.26 % |
| Ordinary shares | 8,127 | 0.26 % | |
S SPAREBANK 1 NORD-NORGE PORTEFØLJE AS | Ordinary shares | 8,094 | 0.26 % |
V VILLEMHAUGEN INVEST AS | Ordinary shares | 7,700 | 0.24 % |
G GREEN ENERGY CONSULTING AS | Ordinary shares | 7,500 | 0.24 % |
S SÅKORNINVEST MIDT-NORGE AS | Ordinary shares | 7,131 | 0.23 % |
B BÅTSTØ BRUG AS | Ordinary shares | 6,900 | 0.22 % |
ØR 1962 | Ordinary shares | 6,324 | 0.2 % |
K KRÆMER AS | Ordinary shares | 5,758 | 0.18 % |
T TAVE INVEST AS | Ordinary shares | 5,616 | 0.18 % |
J JESEM AS | Ordinary shares | 5,395 | 0.17 % |
B BUGAHEIA HOLDING AS | Ordinary shares | 5,150 | 0.16 % |
HR | Ordinary shares | 5,100 | 0.16 % |
PA | Ordinary shares | 5,000 | 0.16 % |
CD | Ordinary shares | 5,000 | 0.16 % |
KA | Ordinary shares | 5,000 | 0.16 % |
T TROMS KRAFT AS | Ordinary shares | 4,998 | 0.16 % |
H HARILA INVEST AS | Ordinary shares | 4,941 | 0.16 % |
Ø ØKSNES INVEST AS | Ordinary shares | 4,328 | 0.14 % |
P PAACS INVEST AS | Ordinary shares | 4,170 | 0.13 % |
K KRANE AS | Ordinary shares | 3,620 | 0.11 % |
M MYRBAKK EIENDOM AS | Ordinary shares | 3,620 | 0.11 % |
J JGB CORPORATE AS | Ordinary shares | 3,450 | 0.11 % |
H HAUKELAND AS | Ordinary shares | 3,403 | 0.11 % |
PW | Ordinary shares | 3,123 | 0.1 % |
C COLLETT & CO. AS | Ordinary shares | 3,100 | 0.1 % |
V VFO INVEST AS | Ordinary shares | 3,072 | 0.1 % |
J JPB AS | Ordinary shares | 2,917 | 0.09 % |
B BODØ LEGETJENESTER AS | Ordinary shares | 2,912 | 0.09 % |
W WEAB INVEST AS | Ordinary shares | 2,821 | 0.09 % |
G GADD HOLDING AS Closed | Ordinary shares | 2,775 | 0.09 % |
KM | Ordinary shares | 2,564 | 0.08 % |
VF | Ordinary shares | 2,564 | 0.08 % |
MG | Ordinary shares | 2,561 | 0.08 % |
S SYMBIA AS | Ordinary shares | 2,560 | 0.08 % |
S SUNDSVOLD HOLDING AS | Ordinary shares | 2,558 | 0.08 % |
KB 1975 | Ordinary shares | 2,500 | 0.08 % |
G GILL GRUPPEN AS | Ordinary shares | 2,445 | 0.08 % |
GN | Ordinary shares | 2,384 | 0.08 % |
H HH HOLDING AS | Ordinary shares | 2,313 | 0.07 % |
S SIRIUS EIENDOM AS | Ordinary shares | 2,248 | 0.07 % |
S SUCABE INVEST AS | Ordinary shares | 2,147 | 0.07 % |
SJ | Ordinary shares | 2,100 | 0.07 % |
K KARDIOKONSULT AS | Ordinary shares | 2,000 | 0.06 % |
D DBTECH AS | Ordinary shares | 2,000 | 0.06 % |
E EXACT ESTIMATES AS | Ordinary shares | 2,000 | 0.06 % |
P PARG INVEST AS | Ordinary shares | 2,000 | 0.06 % |
RS 1992 | Ordinary shares | 2,000 | 0.06 % |
| Ordinary shares | 2,000 | 0.06 % | |
L LÅS & BESLAG CONSULT AS | Ordinary shares | 1,958 | 0.06 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 989,892 | 1,379,500 | 1,520,225 | 538,481 |
Annual Total Result | -2,810,897 | -1,750,939 | -2,187,344 | -3,247,715 |
Total assets | 1,534,549 | 5,180,231 | 1,424,240 | 3,471,396 |
Total liabilities | 1,560,124 | 2,394,909 | 2,313,211 | 2,173,024 |
Total equity | -25,575 | 2,785,322 | -888,971 | 1,298,372 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 989,892 | 1,379,500 | 1,520,225 | 538,481 |
Total operating costs | 3,823,503 | 2,836,525 | 3,706,240 | 3,777,146 |
Operating result | -2,833,611 | -1,457,025 | -2,186,015 | -3,238,665 |
Financial income/costs | 22,714 | -293,914 | -1,328 | -9,050 |
Profit before tax | -2,810,897 | -1,750,939 | -2,187,344 | -3,247,715 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -2,810,897 | -1,750,939 | -2,187,344 | -3,247,715 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 3,224 | 16,100 | 28,976 | 0 |
Total current assets | 1,531,325 | 5,164,131 | 1,395,264 | 3,471,396 |
Total assets | 1,534,549 | 5,180,231 | 1,424,240 | 3,471,396 |
Short term debt | 491,687 | 1,326,472 | 989,807 | 849,620 |
Long term debt | 1,068,437 | 1,068,437 | 1,323,404 | 1,323,404 |
Total liabilities | 1,560,124 | 2,394,909 | 2,313,211 | 2,173,024 |
Contributed capital | 316,642 | 2,785,322 | 287,078 | 1,298,372 |
Retained earnings | -342,217 | 0 | -1,176,050 | 0 |
Total equity | -25,575 | 2,785,322 | -888,971 | 1,298,372 |
Total equity and liabilities | 1,534,549 | 5,180,231 | 1,424,240 | 3,471,396 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises